Azithromycin tied to poor airflow decline-free survival after HSCT

August 9, 2017

(HealthDay)—For patients after allogeneic hematopoietic stem cell transplant (HSCT), early administration of azithromycin is associated with worse airflow decline-free survival, according to a study published in the Aug. 8 issue of the Journal of the American Medical Association.

Anne Bergeron, M.D., Ph.D., from the Hôpital Saint-Louis in Paris, and colleagues randomized patients to receive or placebo three times per week for two years (243 and 237 patients, respectively), starting at the time of the conditioning regimen.

The independent data and safety monitoring board detected an unanticipated imbalance across blinded groups in terms of the number of hematological relapses at 13 months after enrollment, and treatment was stopped. The researchers found that the two-year airflow decline-free survival was 32.8 and 41.3 percent with azithromycin and placebo, respectively (unadjusted hazard ratio, 1.3). Overall, 15 (6 percent) in the azithromycin group and seven (3 percent) in the experienced bronchiolitis obliterans (P = 0.08). Increased mortality was seen in the azithromycin group, with two-year survival of 56.6 and 70.1 percent in the azithromycin and placebo groups, respectively (unadjusted hazard ratio, 1.5). The two-year cumulative incidence of hematological relapse was 33.5 and 22.3 percent with azithromycin and placebo, respectively (unadjusted cause-specific hazard ratio, 1.7).

"Early administration of azithromycin resulted in worse airflow decline-free survival than did ; these findings are limited by early trial termination," the authors write.

Several authors disclosed financial ties to pharmaceutical and respiratory assistance companies, including SOS Oxygène, which partially funded the study.

Explore further: Prophylactic azithromycin benefit lasts after lung transplant

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Prophylactic azithromycin benefit lasts after lung transplant

August 13, 2015
(HealthDay)—For patients undergoing lung transplantation (LTx), prophylactic azithromycin is associated with reduced risk of chronic lung allograft dysfunction (CLAD), according to a study published online Aug. 4 in the ...

Azithromycin given in labor cuts maternal, neonatal infections

January 31, 2017
(HealthDay)—Administration of azithromycin during labor is associated with a reduction in maternal and neonatal clinical infections, according to a study published online Jan. 27 in Pediatrics.

Efficacy of azithromycin in chlamydia remains high

December 29, 2015
(HealthDay)—Azithromycin is not noninferior to doxycycline for treatment of urogenital chlamydia infection among adolescents; however, the efficacy of both types of treatment is high, according to a study published in the ...

Azithromycin prescribed despite risk for QTc prolongation

January 12, 2016
(HealthDay)—Azithromycin is frequently prescribed to hospitalized patients despite the presence of risk factors for QTc prolongation, according to a study published in the January issue of the Journal of Hospital Medicine.

Azithromycin routine in hospital despite risk for QTc prolongation

August 31, 2015
(HealthDay)—Azithromycin is routinely prescribed to hospitalized patients despite risk factors for corrected QT (QTc) prolongation and administration of interacting medications, according to a study published online Aug. ...

Longer survival for midostaurin and chemotherapy in AML with FLT3

June 26, 2017
(HealthDay)—For patients with acute myeloid leukemia (AML) and a FLT3 mutation, midostaurin plus chemotherapy is associated with prolonged overall and event-free survival, according to a study published online June 23 in ...

Recommended for you

Researchers investigate the potential of spider silk protein for engineering artificial heart

August 18, 2017
Ever more people are suffering from cardiac insufficiency, despite significant advances in preventing and minimising damage to the heart. The main cause of reduced cardiac functionality lies in the irreversible loss of cardiac ...

Lasers used to detect risk of heart attack and stroke

August 18, 2017
Patients at risk of heart attacks and strokes may be spotted earlier thanks to a diagnosis tool that uses near-infrared light to identify high-risk arterial plaques, according to research carried out at WMG, University of ...

How Gata4 helps mend a broken heart

August 15, 2017
During a heart attack, blood stops flowing into the heart; starved for oxygen, part of the heart muscle dies. The heart muscle does not regenerate; instead it replaces dead tissue with scars made of cells called fibroblasts ...

Injectable tissue patch could help repair damaged organs

August 14, 2017
A team of U of T Engineering researchers is mending broken hearts with an expanding tissue bandage a little smaller than a postage stamp.

'Fat but fit' are at increased risk of heart disease

August 14, 2017
Carrying extra weight could raise your risk of heart attack by more than a quarter, even if you are otherwise healthy.

Air pollution linked to cardiovascular disease; air purifiers may lessen impact

August 14, 2017
Exposure to high levels of air pollution increased stress hormone levels and negative metabolic changes in otherwise healthy, young adults in a recent study conducted in China. Air purifiers appeared to lessen the negative ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.